Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00372918 · ClinicalTrials.gov registry record · Phase 4
Interpretation of Transnasal Esophagoscopy Findings
A Phase 4 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 4
- Development phase
- 98
- Enrollment target
NCT00372918 is a Phase 4 study that has completed, run by Vanderbilt University. The registered enrollment target is 98 participants.
The verdict
NCT00372918, a Phase 4 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 98 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the prevalence of esophageal pathology in patients with voice disorders. In addition, , the intra- and interdisciplinary variability regarding the identification of esophageal pathology will be analyzed in this study.
Interventions
- PROCEDURE Transnasal Esophagoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2006-09 |
| Est. Completion | 2008-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00372918
The ClinicalTrials.gov registry entry for NCT00372918 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transnasal Esophagoscopy is the first listed.
NCT00372918 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00372918 about?
NCT00372918 is a clinical study titled "Interpretation of Transnasal Esophagoscopy Findings". The purpose of this study is to determine the prevalence of esophageal pathology in patients with voice disorders. In addition, , the intra- and interdisciplinary variability regarding the identification of esophageal pathology will be analyzed in this study.
What is the current status of trial NCT00372918?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 98 participants. The study started on 2006-09. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00372918?
The interventions under investigation include: Transnasal Esophagoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT00372918?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.